NCT05911503View on ClinicalTrials.gov

Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

June 1, 2027

Study Completion Date

June 30, 2027

Conditions
Cytomegalovirus RetinitisGanciclovir Eye Drops
Interventions
DRUG

2% Ganciclovir Eye Drops

Administration method and dosage adjustment: 2% ganciclovir eye drops, 10 times/day for two weeks, 8 times/day for two weeks, 6 times/day for two weeks, 4 times/day for more than 6 weeks

Trial Locations (1)

300000

RECRUITING

Tianjin Medical University Eye Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Medical University

OTHER